Keywords = GDP – NHL – Relapsed – Refractory lymphoma
Outcome of Second Line Chemotherapy (Gemcitabine, Dexamethasone, and Cisplatin) in Relapsed and Refractory Non Hodgkin Lymphoma

Volume 86, December, December 2018, Pages 3519-3524

YOUSRYEIA A. AHMAD, M.D.; RANIA HAFEZ, M.D.; SABRIN REFAAT, M.Sc.; MARWA ISMAIL, M.D.